TORONTO, July 17, 2018 /CNW/ - Pure Global Cannabis Inc. (TSXV: PURE) (OTC: PRCNF) (the "Company" or "PURE" or "Pure Global") is pleased to announce the appointment of Rachel Colic and Stephen Pynn to the Company's Senior Management Team. As VP Brand Strategy, Ms. Colic will be responsible for leading the Company's strategic marketing endeavours including positioning for the PURE family of brands in both the medical and adult-use markets. As VP Corporate Development, Mr. Pynn will assume responsibility for PURE's corporate strategic objectives and investor communications.
"We are extremely pleased to welcome both Rachel and Stephen to the Pure Global team," says Malay Panchal, President & CEO of Pure Global. "They are both integral parts of PURE's strategic vision to become the most trusted global cannabis brand while expanding our quality investor base."
Ms. Colic joins the Company with over 15 years of success in the B2B and B2C marketing spheres. Rachel is a frequent writer and speaker on strategic branding, and noted advocate on using cannabis as a medicine. Rachel is the co-host of The High Friends Podcast™, a show focused on women and their love of cannabis; and a mentor and advisor for Leaf Forward, Canada's first cannabis business-accelerator program. Prior to joining the Company, Rachel spent four years working exclusively in the cannabis space with Licensed Producers, ancillary service companies and startups in the both the US and Canada.
"I'm thrilled to be joining the PURE family. Their focus on putting patients first and setting the global standard for cannabis medicine is inspiring, and I'm grateful to lend my expertise to their mission," said Ms. Colic. "The calibre of leadership within this team blew me away from the first time we met, and I'm confident the Company is poised to make significant impacts in the Canadian cannabis markets and beyond."
Mr. Pynn brings a significant amount of Capital Markets, Corporate Finance and cannabis experience to Pure Global. Stephen joins the Company from PI Financial Corp., an independent investment bank where he was an integral member of the Capital Markets team. Stephen's focus was primarily on the cannabis sector, having been involved in numerous financings and public offerings. Prior to that, Stephen worked at CIBC World Markets from 2007 to 2017 specializing in North American equities. Stephen holds a B.Comm (Hons.) degree from the Memorial University of Newfoundland.
"We are entering a remarkable new era both domestically and internationally as we shed the stigmas of the past and embrace the possibilities of cannabis. As the world begins to recognize the tremendous benefits of medical cannabis, Pure Global will be there, developing world-class formulations for our patients and value for our investors."
In addition to Ms. Colic and Mr. Pynn, the Pure Global team is comprised of seasoned pharma-industry experts including Chairman Dr. Chandra Panchal, PhD, whose distinguished resume includes Director for MaRS Innovation, Senior Scientist at John Labatt Ltd., and Chairman, President & CEO at Procyon Biopharma Inc., and VP of Production & Master Grower Nader Gheshlaghi, PhD, a world-renowned specialist in plant genetics and commercial-scale indoor and greenhouse horticulture.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSXV: PURE; OTC: PRCNF) is a growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, and supply chain experts. The Company's wholly-owned subsidiary, PureSinse, is a licensed producer under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") focused on producing premium-quality cannabis products for medical, wellness, and future legal adult recreational use. The Company is launching Canada's first multi-ponic cannabis farm – a patent-pending system that is expected to produce several fold greater yields over traditional methods while reducing cost and eliminating pesticide and herbicide use.
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Pure Global Cannabis Inc.
For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: email@example.com; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: firstname.lastname@example.org